Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects

NCT00956449 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Seasonal Influenza

Interventions

BIOLOGICAL: Seasonal Influenza Vaccine

Sponsor

Novartis

Collaborators

[object Object]